2018
DOI: 10.1016/j.diabres.2018.05.022
|View full text |Cite
|
Sign up to set email alerts
|

The effect of Ramadan fasting and continuing sodium-glucose co-transporter-2 (SGLT2) inhibitor use on ketonemia, blood pressure and renal function in Muslim patients with type 2 diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
47
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(50 citation statements)
references
References 17 publications
2
47
0
1
Order By: Relevance
“…Moreover, in our characterisation of biological biomarkers (blood pressure, CRP, glucose levels), we observed that the elderly may receive more benefits from fasting than younger men, due either to the fact elderly are more susceptible to the extreme variations in nutriments intakes, to the longer experience and better management of fasting or simply to the fact they are the at-risk population [33]. Our study also describes the novel effect of fasting on biomarkers associated with physiological functions—such as orexin-A (wakefulness) [34], β-hydroxybutyrate (non-conventional metabolic pathways) [35] and PDGF-AA (aging/senescence) [36].…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, in our characterisation of biological biomarkers (blood pressure, CRP, glucose levels), we observed that the elderly may receive more benefits from fasting than younger men, due either to the fact elderly are more susceptible to the extreme variations in nutriments intakes, to the longer experience and better management of fasting or simply to the fact they are the at-risk population [33]. Our study also describes the novel effect of fasting on biomarkers associated with physiological functions—such as orexin-A (wakefulness) [34], β-hydroxybutyrate (non-conventional metabolic pathways) [35] and PDGF-AA (aging/senescence) [36].…”
Section: Discussionmentioning
confidence: 99%
“…Earlier research also supports the greater risk of hypoglycaemia with SUs compared metformin monotherapy [ 62 ]. A number of studies have also shown the lower risk of hypoglycaemia with newer T2 diabetes therapies compared to SUs and their safety in Ramadan fasting [ 58 , 59 , 63 71 ].…”
Section: Specific Risks and Metabolic Parameters In Diabetes In Relatmentioning
confidence: 99%
“…Both groups had a similar change in weight, eGFR, sitting systolic, sitting diastolic blood pressure and plasma β-OHB level. The proportion of patients experiencing at least one hypoglycaemic event during fasting non-significantly increased in the control group and decreased in the study group [ 63 ].…”
Section: Managementmentioning
confidence: 99%
“…Finally, in terms of renal function parameters, studies investigating the effect of Ramadan fasting show that there was a significant reduction in serum creatinine, estimated glomerular filtration rate (eGFR) and urinary albumin/creatinine ratio in healthy individuals, but the decline was within the normal range [ 20 ]. In Muslim patients with type 2 diabetes, there was also a significant decrease in eGFR after Ramadan fasting [ 21 ]. In patients with chronic kidney disease (CKD), one study showed that there was an increase in serum creatinine in those who fasted [ 22 ], while no significant change was observed in another study [ 23 ].…”
Section: Changes In Dietary Intakementioning
confidence: 99%